| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.008 | 0.9 |